A detailed history of Fin Trust Capital Advisors, LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 7 shares of GMED stock, worth $583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 7 -0.0%
Holding current value
$583
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$49.1 - $62.37 $20,769 - $26,382
-423 Reduced 98.37%
7 $0
Q3 2022

Oct 20, 2022

BUY
$55.32 - $67.54 $1,106 - $1,350
20 Added 4.88%
430 $28,000
Q2 2022

Jul 26, 2022

BUY
$53.08 - $81.37 $4,193 - $6,428
79 Added 23.87%
410 $23,000
Q4 2021

Feb 14, 2022

BUY
$62.62 - $79.92 $1,878 - $2,397
30 Added 9.97%
331 $24,000
Q1 2021

May 17, 2021

SELL
$60.05 - $67.74 $5,344 - $6,028
-89 Reduced 22.82%
301 $19,000
Q4 2020

Feb 16, 2021

BUY
$48.89 - $65.87 $19,067 - $25,689
390 New
390 $25,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.43B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.